Loading
Life sciences · Preprint
arXiv · October 9, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Preprint.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Generative molecular design typically relies on over-generation and post-hoc filtering. Inference-time steering methods like Feynman-Kac (FK) steering improve efficiency by biasing trajectories toward high-reward candidates, yet they optimize within a single fixed configuration. In de novo nanobody design, upfront commitment to conditioning choices like scaffold identity or target epitope creates a bottleneck. Since yield varies across these conditions, steering unpromising setups wastes compute. We recast generative condition selection as an inference-time resource-allocation problem. We propose two dynamic budget allocators: a joint Global Sequential Monte Carlo (SMC) formulation that steers and allocates compute across configurations concurrently, and a decoupled approach adapting Batched Successive Elimination (BaSE). Empirically, these dynamic allocators increase the yield of designable candidates per GPU-hour nearly 5$\times$ without sacrificing diversity across distinct therapeutic targets and generative configurations.